How A Small Tweak In The Patent System 25 Years Ago Hurts You Today

from the doesn't-look-good dept

Usually when we're talking about issues with the patent system, we're focused on how it applies to technology -- often software. However, one area where people always like to insist we're completely wrong about patents often causing more problems than they solve is in the pharmaceutical field. With the cost of pharmaceutical research so high, the claim is, no new drugs would ever get made without strong patent protection. Of course, it turns out that patents are being abused badly in the pharmaceutical/medical field as well -- often in much the same way as technology patents. Slashdot points to this fascinating article in Fortune that shows how federally funded, University owned patents have been used to stifle innovation repeatedly, driving up costs significantly. And, the unintended consequences go much further. Because of the lucrative nature of these kinds of patents, researchers no longer share information with each other. As the article makes clear, plenty of medical research breakthroughs came about as people built on the ideas of others. However, now, many researchers (and the universities that employ them) are staying as quiet as possible until patents are filed -- thus slowing down the collaboration needed for real innovation. In fact, the article looks at the biotech field that was supposedly created by the change in patent law that made it easier for universities to license their patents and found plenty of evidence that rather than create a booming industry, the system has actually harmed real innovation, slowed drug discovery for certain diseases and (of course) driven up prices for everyone.

Reader Comments (rss)

(Flattened / Threaded)

  1. identicon
    Tim, Sep 15th, 2005 @ 3:38am

    No Subject Given

    It's been nearly 3 weeks, but I don't see people talking about the role of pharmaceutical patents in the inclusion of bulk drugs in India's aid offering:

    It does't take much effort to wonder if some of these drugs were patented in the US leading to production and distribution problems.

    Actually, does anyone know if the US actually *accepted* this offer, anyway?

    reply to this | link to this | view in thread ]

Add Your Comment

Have a Techdirt Account? Sign in now. Want one? Register here
Get Techdirt’s Daily Email
Save me a cookie
  • Note: A CRLF will be replaced by a break tag (<br>), all other allowable HTML will remain intact
  • Allowed HTML Tags: <b> <i> <a> <em> <br> <strong> <blockquote> <hr> <tt>
Follow Techdirt
Insider Shop - Show Your Support!

Report this ad  |  Hide Techdirt ads
Essential Reading
Techdirt Deals
Report this ad  |  Hide Techdirt ads
Techdirt Insider Chat
Report this ad  |  Hide Techdirt ads
Recent Stories
Report this ad  |  Hide Techdirt ads


Email This

This feature is only available to registered users. Register or sign in to use it.